An AllTrials project

NCT04753164: A reported trial by Idorsia Pharmaceuticals Ltd.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT04753164
Title Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Proof-of-concept Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Feb. 16, 2021
Completion date March 21, 2022
Required reporting date March 21, 2023, midnight
Actual reporting date March 6, 2023
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None